| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB726-SP | |||
| Carrier Free | MAB726-500 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF629-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF-426-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-68777-25ul | |||
![N/A TNF RII/TNFRSF1B [HRP]](http://images.novusbio.com/fullsize2/DATA_TNF_RII_DRT200_ELISA_817.jpg "N/A TNF RII/TNFRSF1B [HRP]")
![N/A TNF RII/TNFRSF1B [HRP]](http://images.novusbio.com/fullsize2/DATA_TNF_RII_DRT200_ELISA_818.jpg)
![N/A TNF RII/TNFRSF1B [HRP]](http://images.novusbio.com/fullsize2/TNF_RII_DRT200_ELISA_176.jpg)
![N/A TNF RI/TNFRSF1A [HRP]](http://images.novusbio.com/fullsize2/DATA_TNF_RI_DRT100_ELISA_815.jpg "N/A TNF RI/TNFRSF1A [HRP]")
![N/A TNF RI/TNFRSF1A [HRP]](http://images.novusbio.com/fullsize2/DATA_TNF_RI_DRT100_ELISA_816.jpg)
![N/A TNF RI/TNFRSF1A [HRP]](http://images.novusbio.com/fullsize2/TNF_RI_DRT100_ELISA_175.jpg)
![N/A TNF RII/TNFRSF1B [Biotin]](http://images.novusbio.com/fullsize2/DATA_TNF_RII_DY726_ELISA_2198.jpg "N/A TNF RII/TNFRSF1B [Biotin]")
![Representative immunohistochemical staining for TNFR1 and TNFR2 in the kidneys.(A) Images were captured at 200× (a, b, c, d, i, j, k, l) and 100× (e, f, g, h, m, n, o, p) magnification. Images show the negative controls in the glomeruli (a, i) and tubulointerstitium (e, m) and TNFR1 and TNFR2 immunostaining in the glomeruli (b, j) and tubulointerstitium (f, n) of the normal kidneys, respectively. TNFR1 and TNFR2 immunostaining is shown in the glomeruli (c, k) and tubulointerstitium (g, o) of the kidneys from selected IgAN patients who had levels of serum TNFR2 that ranked in the lowest 10 [low group (LG)]. TNFR1 and TNFR2 immunostaining in the glomeruli (d, l) and tubulointerstitium (h, p) of the kidneys from selected IgAN patients who had levels of serum TNFR2 that ranked in the highest 10 [high group (HG)], respectively, are also shown. (B) Percentage of the TNFR1 and TNFR2-positive area in the kidneys were evaluated. Glomerular and tubulointerstitial TNFR expression was elevated significantly in IgAN patients compared with those in control (Ctrl) subjects. The tubulointerstitial TNFR2-positive area was significantly larger in HG than in LG. However, there was no significant difference in the tubulointerstitial TNFR1 and glomerular TNFR areas between LG and HG. * P < 0.01, **P < 0.001, †P < 0.0001. Image collected and cropped by CiteAb from the following publication (//dx.plos.org/10.1371/journal.pone.0122212), licensed under a CC-BY license. Not internally tested by R&D Systems.](http://images.novusbio.com/fullsize/mab226_human-tnf-rii-tnfrsf1b-mab-clone-22221-41202410484321.jpg)
![N/A TNF RII/TNFRSF1B [HRP]](http://images.novusbio.com/fullsize2/DATA_TNF_RII_MRT20_ELISA_1029.jpg "N/A TNF RII/TNFRSF1B [HRP]")
![N/A TNF RII/TNFRSF1B [HRP]](http://images.novusbio.com/fullsize2/TNF_RII_MRT20_ELISA_319.jpg)
![N/A TNF RII/TNFRSF1B [HRP]](http://images.novusbio.com/fullsize2/TNF_RII_MRT20_ELISA_320.jpg)
![Representative immunohistochemical staining for TNFR1 and TNFR2 in the kidneys.(A) Images were captured at 200× (a, b, c, d, i, j, k, l) and 100× (e, f, g, h, m, n, o, p) magnification. Images show the negative controls in the glomeruli (a, i) and tubulointerstitium (e, m) and TNFR1 and TNFR2 immunostaining in the glomeruli (b, j) and tubulointerstitium (f, n) of the normal kidneys, respectively. TNFR1 and TNFR2 immunostaining is shown in the glomeruli (c, k) and tubulointerstitium (g, o) of the kidneys from selected IgAN patients who had levels of serum TNFR2 that ranked in the lowest 10 [low group (LG)]. TNFR1 and TNFR2 immunostaining in the glomeruli (d, l) and tubulointerstitium (h, p) of the kidneys from selected IgAN patients who had levels of serum TNFR2 that ranked in the highest 10 [high group (HG)], respectively, are also shown. (B) Percentage of the TNFR1 and TNFR2-positive area in the kidneys were evaluated. Glomerular and tubulointerstitial TNFR expression was elevated significantly in IgAN patients compared with those in control (Ctrl) subjects. The tubulointerstitial TNFR2-positive area was significantly larger in HG than in LG. However, there was no significant difference in the tubulointerstitial TNFR1 and glomerular TNFR areas between LG and HG. * P < 0.01, **P < 0.001, †P < 0.0001. Image collected and cropped by CiteAb from the following publication (//dx.plos.org/10.1371/journal.pone.0122212), licensed under a CC-BY license. Not internally tested by R&D Systems.](http://images.novusbio.com/fullsize/mab225_human-tnf-ri-tnfrsf1a-mab-clone-16803-41202410481119.jpg)
![Immunocytochemistry/Immunofluorescence: Lymphotoxin beta R/TNFRSF3 Antibody [NBP2-68777] - Staining of human cell line RT4 shows localization to the Golgi apparatus.](http://images.novusbio.com/fullsize/Lymphotoxin-beta-R-TNFRSF3-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-68777-img0001.jpg "Immunocytochemistry/Immunofluorescence: Lymphotoxin beta R/TNFRSF3 Antibody [NBP2-68777] - Staining of human cell line RT4 shows localization to the Golgi apparatus.")
![Immunoprecipitation:Lymphotoxin beta R/TNFRSF3 AntibodyNBP3-29385] -Detection of human LTBR by western blot of immunoprecipitates. Samples: Whole cell lysate (0.5 or 1.0 mg per IP reaction; 20% of IP loaded) from HeLa cells prepared using NETN lysis buffer. Antibodies: Affinity purified rabbit anti-LTBR antibody NBP3-29385 (lot NBP3-29385-1) used for IP at 6 µg per reaction. LTBR was also immunoprecipitated by rabbit anti-LTBR.. For blotting immunoprecipitated LTBR, NBP3-29385 was used at 0.4 µg/ml. Detection: Chemiluminescence with an exposure time of 30 seconds.](http://images.novusbio.com/fullsize/nbp3-29385_rabbit-lymphotoxin-beta-r-tnfrsf3-pab-301220241321397.jpg "Immunoprecipitation:Lymphotoxin beta R/TNFRSF3 AntibodyNBP3-29385] -Detection of human LTBR by western blot of immunoprecipitates. Samples: Whole cell lysate (0.5 or 1.0 mg per IP reaction; 20% of IP loaded) from HeLa cells prepared using NETN lysis buffer. Antibodies: Affinity purified rabbit anti-LTBR antibody NBP3-29385 (lot NBP3-29385-1) used for IP at 6 µg per reaction. LTBR was also immunoprecipitated by rabbit anti-LTBR.. For blotting immunoprecipitated LTBR, NBP3-29385 was used at 0.4 µg/ml. Detection: Chemiluminescence with an exposure time of 30 seconds.")
![Immunoprecipitation:Lymphotoxin beta R/TNFRSF3 AntibodyNBP3-29782] -Detection of human LTBR by western blot of immunoprecipitates. Samples: Whole cell lysate (0.5 or 1.0 mg per IP reaction; 20% of IP loaded) from HeLa cells prepared using NETN lysis buffer. Antibodies: Affinity purified rabbit anti-LTBR antibody NBP3-29782 (lot NBP3-29782-1) used for IP at 6 µg per reaction. LTBR was also immunoprecipitated by rabbit anti-LTBR.. For blotting immunoprecipitated LTBR, NBP3-29782 was used at 0.4 µg/ml. Detection: Chemiluminescence with an exposure time of 30 seconds.](http://images.novusbio.com/fullsize/nbp3-29782_rabbit-lymphotoxin-beta-r-tnfrsf3-pab-30122024124406.jpg "Immunoprecipitation:Lymphotoxin beta R/TNFRSF3 AntibodyNBP3-29782] -Detection of human LTBR by western blot of immunoprecipitates. Samples: Whole cell lysate (0.5 or 1.0 mg per IP reaction; 20% of IP loaded) from HeLa cells prepared using NETN lysis buffer. Antibodies: Affinity purified rabbit anti-LTBR antibody NBP3-29782 (lot NBP3-29782-1) used for IP at 6 µg per reaction. LTBR was also immunoprecipitated by rabbit anti-LTBR.. For blotting immunoprecipitated LTBR, NBP3-29782 was used at 0.4 µg/ml. Detection: Chemiluminescence with an exposure time of 30 seconds.")